Cancer Immunology Research · 2023 · 44 citations · 55 references
MedicineImmunologyOncologyMolecular OncologyTumor MicroenvironmentTumor ProgressionCancer ImmunotherapyImmunotherapy For Solid TumorsMyeloid-derived Suppressor CellsPancreatic CancerSignal Transduction In CancerTumor Microenvironment ModulationExosome-mediated Immune SuppressionExosomesExosomes In CancerImmunosuppressive FunctionMacrophage MigrationMyeloid-derived Suppressor Cell FunctionMyeloid-derived Suppressor Cell ModulationTumor-derived Exosomes
Pancreatic cancer is a deadly disease that is largely resistant to immunotherapy, in part because of the accumulation of immunosuppressive cells in the tumor microenvironment (TME). Much evidence suggests that tumor-derived exosomes (TDE) contribute to the immunosuppressive activity mediated by myeloid-derived suppressor cells (MDSC) within the pancreatic cancer TME. However, the underlying mechanisms remain elusive. Herein, we report that macrophage migration inhibitory factor (MIF) in TDEs has a key role in inducing MDSC formation in pancreatic cancer. We identified MIF in both human and murine pancreatic cancer-derived exosomes. Upon specific shRNA-mediated knockdown of MIF, the ability of pancreatic cancer-derived exosomes to promote MDSC differentiation was abrogated. This phenotype was rescued by reexpression of the wild-type form of MIF rather than a tautomerase-null mutant or a thiol-protein oxidoreductase-null mutant, indicating that both MIF enzyme activity sites play a role in exosome-induced MDSC formation in pancreatic cancer. RNA sequencing data indicated that MIF tautomerase regulated the expression of genes required for MDSC differentiation, recruitment, and activation. We therefore developed a MIF tautomerase inhibitor, IPG1576. The inhibitor effectively inhibited exosome-induced MDSC differentiation in vitro and reduced tumor growth in an orthotopic pancreatic cancer model, which was associated with decreased numbers of MDSCs and increased infiltration of CD8+ T cells in the TME. Collectively, our findings highlight a pivotal role for MIF in exosome-induced MDSC differentiation in pancreatic cancer and underscore the potential of MIF tautomerase inhibitors to reverse the immunosuppressive pancreatic cancer microenvironment, thereby augmenting anticancer immune responses.
55
Rebecca L. Siegel, Kimberly D. Miller, Hannah E. Fuchs et al. · CA A Cancer Journal for Clinicians · 2022 · 18.2K citations · Full text
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Bruno Costa‐Silva, Nicole M. Aiello, Allyson J. Ocean et al. · Nature Cell Biology · 2015 · 2.7K citations · Full text
Medicine, Cancer Biology, Oncology +14
HERG, a Human Inward Rectifier in the Voltage-Gated Potassium Channel Family
Matthew C. Trudeau, Jeffrey W. Warmke, Barry Ganetzky et al. · Science · 1995 · 1.2K citations
Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer
Srinivas Nagaraj, Kapil Gupta, Leo Kinarsky et al. · Nature Medicine · 2007 · 1.1K citations · Full text
Life Sciences, Immunology, Oncology +14
MIF Signal Transduction Initiated by Binding to CD74
Lin Leng, Christine N. Metz, Yan Fang et al. · The Journal of Experimental Medicine · 2003 · 1.1K citations · Full text